Belle.ai develops AI solutions aimed at improving access to dermatological care and addressing unmet global demands for skin health, according to self-described objectives.

Belle.ai

Belle.ai | 555 followers on LinkedIn. AI for Global Access to Skin Health | In a world where most people have limited access to dermatology, BelleTorus Corporation (“Belle.ai”) helps healthcare professionals address the unmet demands for global skin healthcare. From a smartphone photo, Belle 1K Skin AI™ uses geometric analyses to find comparable possibilities for more than 1,600 skin conditions, which assists healthcare professionals in evaluating their patients and independently assessing their skin. Belle.ai’s technology also proposes objective scoring for standard assessments of immune-mediated skin disorders (psoriasis, eczema, alopecia areata, vitiligo) for patients already diagnosed with these conditions to help healthcare professionals track progression over time.

Tech Executive

Ly Tran

🇿🇦🇺🇸| Product Management Exec | Investor | Beauty Industry OG | Community Builder | Influencer & Digital Marketing | Advisor | I Get S*%T Done

Sinead Norenius-Raniere

Vice President Business Development, North America @ Belle.ai

Don Minton

Global Operations Specialist; Corporate Paralegal

Diane Parke

Centers for Medicare & Medicaid Services selects Belle.ai as one of six inaugural participants in the first quarterly CMS Artificial Intelligence Demo Day, to be held today at CMS headquarters. “Out of a pool of 300 applicants, your health-related AI products and services stood out as exceptional, earning you this opportunity to showcase your innovations,” CMS informed Belle.ai . “We look forward to witnessing your groundbreaking AI solutions at the CMS Artificial Intelligence Demo Day.” #skinai #dermatology #healthequity

A rare U.S. death from Lassa fever reported in Iowa. The person had recently traveled from West Africa. There have been eight travel-associated cases of Lassa fever in the U.S. in the past 55 years. https://lnkd.in/gj2XCzQg

Addressing challenging cases of acne: diet considerations for drug absorption, and the urgent countdown to an acne-free prom https://lnkd.in/gh2pWhfW

As redness of the skin may be harder to detect in those with deeper-hued skin, dermatologists should look out for rosacea symptoms like burning, stinging, itching, or skin sensitivity. "A diagnosis not considered is a diagnosis not made, so we really need to do a better job in this regard.” https://lnkd.in/gcPfZGtt #skinAI #dermatology #healthequity

While leprosy is rare in the United States, Florida is the nation's hotspot. Florida's Brevard County reported 13% of the nation’s 159 leprosy cases in 2020. Are local armadillos transmitting the disease to humans? https://lnkd.in/giet7ZQP

While much of the nation is debating the future of AI, health care providers in rural America are pioneering new uses of it in their practices. https://lnkd.in/ewWs5QgE

Understanding Skin Cancer with Dr. Poch Lor 🧑⚕️ Today, the Torus team had the pleasure of hosting Dr. @Poch Lor from Hautstation, Switzerland. He delivered an insightful lecture on skin cancer and the future of dermatology, significantly enhancing our understanding of this critical topic as it pertains to our current AI health projects. We are deeply grateful for Dr. Poch Lor's visit and look forward to continuing our collaboration with him on AI-driven dermatology applications. #AI #Dermatology #MedicalAI

TORUS AI

As Congo struggles to contain its biggest mpox outbreak and a new variant of the disease emerges, almost no mpox vaccines are available in the country. The spread of mpox in the West was contained with the help of vaccines and treatments. #healthequity #mpox https://lnkd.in/gBf4z-82

Wal-Mart's pullback is the latest example of retail chains struggling to find a profitable model for offering a broad set of healthcare services in their stores. https://lnkd.in/gDAkWjJz

Metric
Company Name	Belle.ai
Symbol
MSH ID	AI:BELLE
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Health Technology
Country	US
Stage
Employee Count
Website	belle.ai
LinkedIn	belle-artificial-intelligence
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	168
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BELL

AI:BELLE

Belle.ai

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue